Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100
Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention
Bioequivalence of subcutaneous and intravenous body-weight-independent high-dose low-molecular-weight heparin Certoparin on anti-Xa, Heptest, and tissue factor pathway inhibitor activity in volunteers
Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination
Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease
Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes
Evaluation of a new automated quantitative d-dimer, Advanced D-Dimer, in patients suspected of venous thromboembolism
Splanchnic extraction and clearance of tissue plasminogen activator (t-PA) after injection of recombinant t-PA (Actilyse ® ) in resting healthy subjects is proportional to the arterial concentration
Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project
Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease
The effect of 6-aminohexanoic acid and fucoidan on the activation of glutamic plasminogen by streptokinase
Acquired type 3-like von Willebrand syndrome preceded full-blown systemic lupus erythematosus
Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion
Rejection of specimens for prothrombin time and relating pre-analytical factors in blood collection